Eagle Pharmaceuticals Inc
NASDAQ:EGRX

Watchlist Manager
Eagle Pharmaceuticals Inc Logo
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Watchlist
Price: 0.45 USD
Market Cap: 5.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of EGRX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EGRX Intrinsic Value
Not Available
Base Case Scenario
Compare EGRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EGRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eagle Pharmaceuticals Inc

Current Assets 187.3m
Cash & Short-Term Investments 15.4m
Receivables 116.3m
Other Current Assets 55.6m
Non-Current Assets 217.5m
PP&E 1m
Intangibles 152.4m
Other Non-Current Assets 64.1m
Current Liabilities 86.6m
Accounts Payable 15.8m
Accrued Liabilities 61.3m
Other Current Liabilities 9.5m
Non-Current Liabilities 66.2m
Long-Term Debt 61.9m
Other Non-Current Liabilities 4.3m
Efficiency

Free Cash Flow Analysis
Eagle Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eagle Pharmaceuticals Inc

Revenue
257.5m USD
Cost of Revenue
-77.6m USD
Gross Profit
179.9m USD
Operating Expenses
-143.8m USD
Operating Income
36.1m USD
Other Expenses
-24m USD
Net Income
12.1m USD
Fundamental Scores

EGRX Profitability Score
Profitability Due Diligence

Eagle Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Healthy Operating Margin
hidden
Profitability
Score

Eagle Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

EGRX Solvency Score
Solvency Due Diligence

Eagle Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Eagle Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EGRX Price Targets Summary
Eagle Pharmaceuticals Inc

There are no price targets for EGRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Eagle Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EGRX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

EGRX Insider Trading
Buy and sell transactions by insiders

EGRX News

Other Videos